Research ArticleBRAIN
Patterns of Disease Spread in Metastatic Breast Carcinoma: Influence of Estrogen and Progesterone Receptor Status
Daniel D. Maki and Robert I. Grossman
American Journal of Neuroradiology June 2000, 21 (6) 1064-1066;
References
- ↵Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, eds SEER Cancer Statistics Review, 1973–1994. Bethesda, MD: National Cancer Institute 1997;124:97-2789
- ↵Pichon MF, Broet P, Magdelenat H, et al. Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers. Br J Cancer 1996;73:1545-1551
- Sheikh MS, Garcia M, Pujol P, Fontana JA, Rochefort H. Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invas & Metast 1994;14:329-336
- Warde P, Detsky AS. Is steroid receptor data useful in patients with metastatic breast cancer? Am J Med Sci 1992;304:9-13
- ↵
- ↵De la Monte SM, Hutchins GM, Moore GW. Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma. Am J Med 1984;76:11-17
- ↵Koenders PG, Beex LV, Langens R, Kloppenborg PW, Smals AG, Benraad TJ. Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. Breast Ca Res & Treat 1991;18:27-32
- ↵Yuh WT, Fisher DJ, Runge VM, et al. Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases. AJNR Am J Neuroradiol 1994;15:1037-1051
In this issue
Advertisement
Patterns of Disease Spread in Metastatic Breast Carcinoma: Influence of Estrogen and Progesterone Receptor Status
Daniel D. Maki, Robert I. Grossman
American Journal of Neuroradiology Jun 2000, 21 (6) 1064-1066;
Jump to section
Related Articles
- No related articles found.
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement